Serina Therapeutics (SER) Non-Current Debt (2019 - 2024)
Serina Therapeutics (SER) posted Non-Current Debt of $693000.0 for Q3 2024, little changed sequentially from $693000.0 in Q2 2024, and little changed YoY from $693000.0 in Q4 2023.
Serina Therapeutics (SER) Non-Current Debt (2019 - 2024) Analysis & Trends
Serina Therapeutics has reported Non-Current Debt for 6 years, with the latest figure at $693000.0 in Q3 2024.
- Quarterly Non-Current Debt changed 0.0% year-over-year to $693000.0 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $693000.0 (changed 0.0% YoY) and the FY2022 annual result came in at $10.5 million, up 72.85% from the prior year.
- Non-Current Debt held at $693000.0 in Q3 2024 per SER's latest filing, from $693000.0 in the prior quarter.
- Over five years, Non-Current Debt peaked at $10.5 million in Q4 2022 and troughed at $693000.0 in Q3 2023.
- A 5-year average of $4.9 million and a median of $5.3 million in 2021 frame the typical range for Non-Current Debt.
- The sharpest annual moves came in 2020 and 2024: Non-Current Debt soared 1520.42% in 2020, then sank 93.12% in 2024.
- Over 5 years, Non-Current Debt stood at $3.9 million in 2020, then soared by 55.44% to $6.1 million in 2021, then soared by 72.85% to $10.5 million in 2022, then plunged by 93.39% to $693000.0 in 2023, then changed by 0.0% to $693000.0 in 2024.
- According to Business Quant data, Non-Current Debt over the past three periods registered $693000.0, $693000.0, and $693000.0 for Q3 2024, Q2 2024, and Q1 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 882.16 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 360.97 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 546.77 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 8.96 Bn |
| 10 | Serina Therapeutics | 46.70 Mn | 23.67 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 693,000.00 |
| Jun 30, 2024 | 693,000.00 |
| Mar 31, 2024 | 693,000.00 |
| Sep 30, 2023 | 693,000.00 |
| Jun 30, 2023 | 10.07 Mn |
| Mar 31, 2023 | 10.01 Mn |
| Dec 31, 2022 | 10.48 Mn |
| Sep 30, 2022 | 8.35 Mn |
| Jun 30, 2022 | 6.76 Mn |
| Mar 31, 2022 | 4.21 Mn |
| Dec 31, 2021 | 6.06 Mn |
| Sep 30, 2021 | 5.81 Mn |
| Jun 30, 2021 | 5.56 Mn |
| Mar 31, 2021 | 5.33 Mn |
| Dec 31, 2020 | 3.90 Mn |
| Sep 30, 2020 | 3.10 Mn |
| Jun 30, 2020 | 1.73 Mn |
| Dec 31, 2019 | 1.53 Mn |
| Sep 30, 2019 | 191,000.00 |